| scholarly article | Q13442814 |
| P50 | author | Peter J. Hotez | Q7174738 |
| Maria Elena Bottazzi | Q28817215 | ||
| Ricardo T. Fujiwara | Q30513841 | ||
| Alex Loukas | Q30513842 | ||
| Bin Zhan | Q85367926 | ||
| Jeffrey Michael Bethony | Q96097192 | ||
| Gaddam Narsa Goud | Q114780932 | ||
| Najju Ranjit | Q114780933 | ||
| P2093 | author name string | Karen Jones | |
| Susana Mendez | |||
| P2860 | cites work | Hookworm: "the great infection of mankind". | Q21090197 |
| Anticoagulant repertoire of the hookworm Ancylostoma caninum | Q24567856 | ||
| Hookworm Infection | Q29544757 | ||
| A multi-enzyme cascade of hemoglobin proteolysis in the intestine of blood-feeding hookworms | Q30763295 | ||
| Characterisation of humoral immune responses in dogs vaccinated with irradiated Ancylostoma caninum. | Q30895084 | ||
| Vaccine efficacy of recombinant cathepsin D aspartic protease from Schistosoma japonicum | Q32156285 | ||
| Proteinases and associated genes of parasitic helminths | Q33600907 | ||
| Influence of Age and Sex on Susceptibility of Dogs to Primary Infection with Ancylostoma caninum | Q34054297 | ||
| A pore-forming haemolysin from the hookworm, Ancylostoma caninum. | Q50789056 | ||
| The Ingestion of Red Blood Cells by Schistosoma mansoni | Q54247460 | ||
| Emerging Patterns of Hookworm Infection: Influence of Aging on the Intensity ofNecatorInfection in Hainan Province, People’s Republic of China | Q56420614 | ||
| IgG1/IgG2 antibody dichotomy in sera of vaccinated or naturally infected dogs with visceral leishmaniosis | Q60227749 | ||
| Comparison of whole blood and purified canine lymphocytes in a lymphocyte-stimulation microassay | Q67324088 | ||
| Persistence of Immunity Following Double Vaccination of Pups with X-Irradiated Ancylostoma caninum Larvae | Q72632064 | ||
| Effect of age of the dog on immunogenic efficiency of double vaccination with x-irradiated Ancylostoma caninum larvae | Q72701710 | ||
| The hookworm platelet inhibitor: functional blockade of integrins GPIIb/IIIa (alphaIIbbeta3) and GPIa/IIa (alpha2beta1) inhibits platelet aggregation and adhesion in vitro | Q77223499 | ||
| Successful vaccination of BALB/c mice against human hookworm (Necator americanus): the immunological phenotype of the protective response | Q78840455 | ||
| Intersection of HIV and Anemia in women of reproductive age: a 10-year analysis of three Zimbabwe demographic health surveys, 2005-2015 | Q104755510 | ||
| Ancylostoma caninum anticoagulant peptide: a hookworm-derived inhibitor of human coagulation factor Xa. | Q34196787 | ||
| Progress in the development of a recombinant vaccine for human hookworm disease: the Human Hookworm Vaccine Initiative | Q34246851 | ||
| Vaccination of dogs with a recombinant cysteine protease from the intestine of canine hookworms diminishes the fecundity and growth of worms | Q34318119 | ||
| Vaccination against gastrointestinal nematode parasites of ruminants using gut-expressed antigens | Q34346516 | ||
| Expression of the Necator americanus hookworm larval antigen Na-ASP-2 in Pichia pastoris and purification of the recombinant protein for use in human clinical trials | Q34438394 | ||
| Mathematical modelling of schistosomiasis japonica: comparison of control strategies in the People's Republic of China. | Q34646760 | ||
| The immunobiology of schistosomiasis | Q34718128 | ||
| Helminth vaccines: from mining genomic information for vaccine targets to systems used for protein expression | Q35143303 | ||
| Digestive proteases of blood-feeding nematodes. | Q35212643 | ||
| The nature and prospects for gut membrane proteins as vaccine candidates for Haemonchus contortus and other ruminant trichostrongyloids | Q35295051 | ||
| Hookworm infection: new developments and prospects for control | Q35881138 | ||
| Immunobiology of hookworm infection | Q36024402 | ||
| Salmonella typhimurium as a basis for a live oral Echinococcus granulosus vaccine | Q38307642 | ||
| Antibodies against a secreted protein from hookworm larvae reduce the intensity of hookworm infection in humans and vaccinated laboratory animals | Q38906805 | ||
| Vaccination with irradiated Ancylostoma caninum third stage larvae induces a Th2 protective response in dogs | Q39013779 | ||
| Cloning, yeast expression, isolation, and vaccine testing of recombinant Ancylostoma-secreted protein (ASP)-1 and ASP-2 from Ancylostoma ceylanicum | Q39030027 | ||
| Effect of vaccination with a recombinant fusion protein encoding an astacinlike metalloprotease (MTP-1) secreted by host-stimulated Ancylostoma caninum third-stage infective larvae | Q39078494 | ||
| Effect of vaccinations with recombinant fusion proteins on Ancylostoma caninum habitat selection in the canine intestine | Q39078499 | ||
| Effect of combining the larval antigens Ancylostoma secreted protein 2 (ASP-2) and metalloprotease 1 (MTP-1) in protecting hamsters against hookworm infection and disease caused by Ancylostoma ceylanicum | Q39244367 | ||
| The nature and causes of "hookworm anemia". | Q40042892 | ||
| Hookworm control as a strategy to prevent iron deficiency | Q41582192 | ||
| Evolutionary and biomedical implications of a Schistosoma japonicum complementary DNA resource. | Q42608417 | ||
| Hookworm aspartic protease, Na-APR-2, cleaves human hemoglobin and serum proteins in a host-specific fashion | Q42693655 | ||
| Rate of reinfection with intestinal nematodes after treatment of children with mebendazole or albendazole in a highly endemic area. | Q43954184 | ||
| Vaccination of calves against Ostertagia ostertagi with cysteine proteinase enriched protein fractions | Q44024611 | ||
| A preliminary evaluation of a recombinant circumsporozoite protein vaccine against Plasmodium falciparum malaria. RTS,S Malaria Vaccine Evaluation Group | Q44174498 | ||
| Cleavage of hemoglobin by hookworm cathepsin D aspartic proteases and its potential contribution to host specificity | Q44432211 | ||
| Metalloendopeptidases from the intestinal brush border of Haemonchus contortus as protective antigens for sheep | Q44594907 | ||
| Protection against systemic candidiasis in mice immunized with secreted aspartic proteinase 2. | Q44792128 | ||
| Aspartyl proteases from the intestinal brush border of Haemonchus contortus as protective antigens for sheep | Q44821782 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | hookworm disease | Q5898175 |
| P304 | page(s) | e295 | |
| P577 | publication date | 2005-10-01 | |
| P1433 | published in | PLOS MEDICINE | Q1686921 |
| P1476 | title | Vaccination with recombinant aspartic hemoglobinase reduces parasite load and blood loss after hookworm infection in dogs | |
| P478 | volume | 2 |
| Q40838149 | A 43 kDa recombinant plasmepsin elicits immune response in mice against Plasmodium berghei malaria |
| Q63984735 | A highly expressed intestinal cysteine protease of Ancylostoma ceylanicum protects vaccinated hamsters from hookworm infection |
| Q35881296 | A history of hookworm vaccine development |
| Q30062048 | Advancing a vaccine to prevent hookworm disease and anemia |
| Q37288854 | An aspartic protease of the scabies mite Sarcoptes scabiei is involved in the digestion of host skin and blood macromolecules |
| Q37326963 | An enzymatically inactivated hemoglobinase from Necator americanus induces neutralizing antibodies against multiple hookworm species and protects dogs against heterologous hookworm infection |
| Q37756146 | Blunting the knife: development of vaccines targeting digestive proteases of blood-feeding helminth parasites |
| Q36131667 | Changes in biochemical analytes in female dogs with subclinical Ancylostoma spp. infection |
| Q55354038 | Characterization of AiiK, an AHL lactonase, from Kurthia huakui LAM0618T and its application in quorum quenching on Pseudomonas aeruginosa PAO1. |
| Q37772265 | Control of important helminthic infections vaccine development as part of the solution |
| Q38176075 | Controlling soil-transmitted helminths: time to think inside the box? |
| Q37800361 | Developing vaccines to combat hookworm infection and intestinal schistosomiasis |
| Q24601973 | Epidemiology and control of human gastrointestinal parasites in children |
| Q58853077 | Evaluation of parasitological and immunological aspects of acute infection by Ancylostoma caninum and Ancylostoma braziliense in mixed-breed dogs |
| Q46147097 | Expression and characterization of aspartic protease gene in eggs and larvae stage of Ancylostoma caninum. |
| Q35887003 | Expression, purification, and characterization of the Necator americanus aspartic protease-1 (Na-APR-1 (M74)) antigen, a component of the bivalent human hookworm vaccine |
| Q39043252 | Fasciola hepatica - the pilot study of in vitro assessing immune response against native and recombinant antigens of the fluke |
| Q30540149 | First transcriptomic analysis of the economically important parasitic nematode, Trichostrongylus colubriformis, using a next-generation sequencing approach |
| Q37403181 | Functional genes and proteins of Clonorchis sinensis |
| Q21266569 | Gene discovery for the carcinogenic human liver fluke, Opisthorchis viverrini |
| Q36826969 | Granule exocytosis of granulysin and granzyme B as a potential key mechanism in vaccine-induced immunity in cattle against the nematode Ostertagia ostertagi |
| Q33898336 | High yield expression of an AHL-lactonase from Bacillus sp. B546 in Pichia pastoris and its application to reduce Aeromonas hydrophila mortality in aquaculture |
| Q57964233 | Hookworm infection |
| Q36635886 | Hookworm vaccines: past, present, and future |
| Q39880059 | IgG subclass profile of serum antibodies to Leishmania chagasi in naturally infected and vaccinated dogs |
| Q95830345 | Immunogenicity and protection induced by recombinant Toxocara canis proteins in a murine model of toxocariasis |
| Q34290786 | Lipid core peptide targeting the cathepsin D hemoglobinase of Schistosoma mansoni as a component of a schistosomiasis vaccine |
| Q39013387 | Lipopeptide Nanoparticles: Development of Vaccines against Hookworm Parasite |
| Q34893725 | Model for product development of vaccines against neglected tropical diseases: a vaccine against human hookworm |
| Q33419513 | Molecular determinants archetypical to the phylum Nematoda |
| Q91982204 | Molecular identification of zoonotic hookworms in dogs from four counties of Kenya |
| Q35887080 | New tools for NTD vaccines: A case study of quality control assays for product development of the human hookworm vaccine Na-APR-1M74 |
| Q36143730 | One ring to rule them all: trafficking of heme and heme synthesis intermediates in the metazoans |
| Q37196249 | Ov-APR-1, an aspartic protease from the carcinogenic liver fluke, Opisthorchis viverrini: functional expression, immunolocalization and subsite specificity |
| Q36845488 | Parasitic nematodes - from genomes to control. |
| Q34442381 | Peptide-based subunit vaccine against hookworm infection |
| Q43902070 | Polyclonal and specific antibodies mediate protective immunity against enteric helminth infection. |
| Q38647737 | Recombinant subunit vaccines for soil-transmitted helminths |
| Q35690054 | Reduction of worm fecundity and canine host blood loss mediates protection against hookworm infection elicited by vaccination with recombinant Ac-16. |
| Q99413019 | Safety and immunogenicity of co-administered hookworm vaccine candidates Na-GST-1 and Na-APR-1 in Gabonese adults: a randomised, controlled, double-blind, phase 1 dose-escalation trial |
| Q33719126 | Safety and immunogenicity of the Na-GST-1 hookworm vaccine in Brazilian and American adults |
| Q42603722 | Saposin-like proteins from the intestine of the blood-feeding hookworm, Ancylostoma caninum |
| Q28238731 | Soil-transmitted helminth infections: ascariasis, trichuriasis, and hookworm |
| Q40715680 | The Use of Microwave-Assisted Solid-Phase Peptide Synthesis and Click Chemistry for the Synthesis of Vaccine Candidates Against Hookworm Infection |
| Q36491789 | The canine hookworm genome: analysis and classification of Ancylostoma caninum survey sequences |
| Q21092392 | The end of the line for hookworm? An update on vaccine development |
| Q21183984 | The genome and transcriptome of Haemonchus contortus, a key model parasite for drug and vaccine discovery |
| Q36130178 | The genome of Strongyloides spp. gives insights into protein families with a putative role in nematode parasitism. |
| Q37291569 | The hookworm Ancylostoma ceylanicum intestinal transcriptome provides a platform for selecting drug and vaccine candidates |
| Q35936503 | The human hookworm vaccine: recent updates and prospects for success |
| Q90324839 | Twenty-five-year research progress in hookworm excretory/secretory products |
| Q38194247 | Vaccination against helminth parasite infections. |
| Q51793755 | Vaccination with Setaria cervi 175 kDa collagenase induces high level of protection against Brugia malayi infection in jirds. |
| Q36726742 | Vaccines against blood-feeding nematodes of humans and livestock |
| Q30425005 | Vaccines to combat the neglected tropical diseases |
| Q37176060 | Worms and the treatment of inflammatory bowel disease: are molecules the answer? |
| Q27646442 | X-ray structures of Na-GST-1 and Na-GST-2 two glutathione s-transferase from the human hookworm Necator americanus |
Search more.